CVS Health Corporation (0HRS.L)
USD 67.18
(-5.26%)
USD 67.18
(-5.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 173.09 Billion USD | 10.28% |
| 2022 | 156.96 Billion USD | -0.42% |
| 2021 | 157.61 Billion USD | -2.11% |
| 2020 | 161.01 Billion USD | 1.73% |
| 2019 | 158.27 Billion USD | 14.77% |
| 2018 | 137.91 Billion USD | 140.12% |
| 2017 | 57.43 Billion USD | -0.33% |
| 2016 | 57.62 Billion USD | 2.08% |
| 2015 | 56.45 Billion USD | 55.57% |
| 2014 | 36.28 Billion USD | 8.04% |
| 2013 | 33.58 Billion USD | 19.07% |
| 2012 | 28.2 Billion USD | 6.6% |
| 2011 | 26.46 Billion USD | 8.3% |
| 2010 | 24.43 Billion USD | -5.56% |
| 2009 | 25.87 Billion USD | -1.94% |
| 2008 | 26.38 Billion USD | 12.76% |
| 2007 | 23.4 Billion USD | 119.67% |
| 2006 | 10.65 Billion USD | 53.22% |
| 2005 | 6.95 Billion USD | -8.03% |
| 2004 | 7.55 Billion USD | 67.2% |
| 2003 | 4.52 Billion USD | 1.64% |
| 2002 | 4.44 Billion USD | 9.53% |
| 2001 | 4.06 Billion USD | 11.42% |
| 2000 | 3.64 Billion USD | 1.37% |
| 1999 | 3.59 Billion USD | -0.82% |
| 1998 | 3.62 Billion USD | 10.69% |
| 1997 | 3.27 Billion USD | 106.43% |
| 1996 | 1.58 Billion USD | -31.57% |
| 1995 | 2.31 Billion USD | 3.33% |
| 1994 | 2.24 Billion USD | 16.25% |
| 1993 | 1.93 Billion USD | -5.19% |
| 1992 | 2.03 Billion USD | 7.82% |
| 1991 | 1.88 Billion USD | 10.85% |
| 1990 | 1.7 Billion USD | 29.98% |
| 1989 | 1.31 Billion USD | 27.25% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 175.59 Billion USD | 1.44% |
| 2024 Q2 | 177.37 Billion USD | 1.01% |
| 2023 Q4 | 173.09 Billion USD | -2.1% |
| 2023 FY | 173.09 Billion USD | 10.28% |
| 2023 Q1 | 167.75 Billion USD | 6.87% |
| 2023 Q2 | 177.06 Billion USD | 5.56% |
| 2023 Q3 | 176.79 Billion USD | -0.15% |
| 2022 Q1 | 158.73 Billion USD | 0.71% |
| 2022 Q2 | 154.77 Billion USD | -2.49% |
| 2022 Q3 | 160.2 Billion USD | 3.51% |
| 2022 Q4 | 156.96 Billion USD | -2.02% |
| 2022 FY | 156.96 Billion USD | -0.42% |
| 2021 Q3 | 160.27 Billion USD | 1.7% |
| 2021 Q4 | 157.61 Billion USD | -1.66% |
| 2021 FY | 157.61 Billion USD | -2.11% |
| 2021 Q1 | 158.44 Billion USD | -1.6% |
| 2021 Q2 | 157.59 Billion USD | -0.53% |
| 2020 Q3 | 163.78 Billion USD | -2.01% |
| 2020 FY | 161.01 Billion USD | 1.73% |
| 2020 Q1 | 165.16 Billion USD | 4.35% |
| 2020 Q2 | 167.14 Billion USD | 1.2% |
| 2020 Q4 | 161.01 Billion USD | -1.69% |
| 2019 Q1 | 159.76 Billion USD | 15.84% |
| 2019 Q3 | 157.18 Billion USD | -0.08% |
| 2019 Q2 | 157.3 Billion USD | -1.54% |
| 2019 Q4 | 158.27 Billion USD | 0.7% |
| 2019 FY | 158.27 Billion USD | 14.77% |
| 2018 FY | 137.91 Billion USD | 140.12% |
| 2018 Q4 | 137.91 Billion USD | 45.35% |
| 2018 Q3 | 94.88 Billion USD | -2.86% |
| 2018 Q2 | 97.67 Billion USD | 1.26% |
| 2018 Q1 | 96.46 Billion USD | 67.95% |
| 2017 Q4 | 57.43 Billion USD | -0.95% |
| 2017 FY | 57.43 Billion USD | -0.33% |
| 2017 Q3 | 57.98 Billion USD | -0.67% |
| 2017 Q2 | 58.37 Billion USD | -0.76% |
| 2017 Q1 | 58.82 Billion USD | 2.08% |
| 2016 Q2 | 57.98 Billion USD | 2.44% |
| 2016 Q1 | 56.6 Billion USD | 0.26% |
| 2016 FY | 57.62 Billion USD | 2.08% |
| 2016 Q3 | 58.2 Billion USD | 0.38% |
| 2016 Q4 | 57.62 Billion USD | -0.99% |
| 2015 Q1 | 36.93 Billion USD | 1.78% |
| 2015 FY | 56.45 Billion USD | 55.57% |
| 2015 Q4 | 56.45 Billion USD | 2.31% |
| 2015 Q3 | 55.18 Billion USD | 47.01% |
| 2015 Q2 | 37.53 Billion USD | 1.62% |
| 2014 Q1 | 34.61 Billion USD | 3.04% |
| 2014 Q3 | 35.46 Billion USD | 2.92% |
| 2014 Q4 | 36.28 Billion USD | 2.32% |
| 2014 FY | 36.28 Billion USD | 8.04% |
| 2014 Q2 | 34.46 Billion USD | -0.43% |
| 2013 Q1 | 27.85 Billion USD | -1.24% |
| 2013 FY | 33.58 Billion USD | 19.07% |
| 2013 Q4 | 33.58 Billion USD | 14.75% |
| 2013 Q3 | 29.27 Billion USD | 6.91% |
| 2013 Q2 | 27.37 Billion USD | -1.73% |
| 2012 Q1 | 27.95 Billion USD | 5.63% |
| 2012 FY | 28.2 Billion USD | 6.6% |
| 2012 Q4 | 28.2 Billion USD | 1.18% |
| 2012 Q3 | 27.88 Billion USD | 0.74% |
| 2012 Q2 | 27.67 Billion USD | -0.99% |
| 2011 Q2 | 27.21 Billion USD | 9.39% |
| 2011 FY | 26.46 Billion USD | 8.3% |
| 2011 Q3 | 27.73 Billion USD | 1.92% |
| 2011 Q4 | 26.46 Billion USD | -4.58% |
| 2011 Q1 | 24.87 Billion USD | 1.8% |
| 2010 Q1 | 25.59 Billion USD | -1.09% |
| 2010 FY | 24.43 Billion USD | -5.56% |
| 2010 Q4 | 24.43 Billion USD | -2.42% |
| 2010 Q3 | 25.04 Billion USD | -2.24% |
| 2010 Q2 | 25.61 Billion USD | 0.1% |
| 2009 Q1 | 25.36 Billion USD | -3.86% |
| 2009 Q3 | 26.2 Billion USD | 5.3% |
| 2009 Q4 | 25.87 Billion USD | -1.26% |
| 2009 Q2 | 24.88 Billion USD | -1.9% |
| 2009 FY | 25.87 Billion USD | -1.94% |
| 2008 Q3 | 22.21 Billion USD | 3.54% |
| 2008 FY | 26.38 Billion USD | 12.76% |
| 2008 Q1 | 22.41 Billion USD | -4.21% |
| 2008 Q2 | 21.45 Billion USD | -4.28% |
| 2008 Q4 | 26.38 Billion USD | 18.77% |
| 2007 Q4 | 23.4 Billion USD | 5.85% |
| 2007 Q3 | 22.1 Billion USD | -2.1% |
| 2007 Q1 | 17 Billion USD | 59.63% |
| 2007 FY | 23.4 Billion USD | 119.67% |
| 2007 Q2 | 22.58 Billion USD | 32.8% |
| 2006 FY | 10.65 Billion USD | 53.22% |
| 2006 Q2 | 11.21 Billion USD | 66.75% |
| 2006 Q1 | 6.72 Billion USD | -3.22% |
| 2006 Q3 | 11.69 Billion USD | 4.22% |
| 2006 Q4 | 10.65 Billion USD | -8.9% |
| 2005 Q3 | 7.27 Billion USD | 2.64% |
| 2005 Q4 | 6.95 Billion USD | -4.38% |
| 2005 Q1 | 7.41 Billion USD | -1.88% |
| 2005 FY | 6.95 Billion USD | -8.03% |
| 2005 Q2 | 7.08 Billion USD | -4.5% |
| 2004 Q1 | 4.08 Billion USD | -9.67% |
| 2004 FY | 7.55 Billion USD | 67.2% |
| 2004 Q2 | 3.98 Billion USD | -2.43% |
| 2004 Q3 | 7.63 Billion USD | 91.52% |
| 2004 Q4 | 7.55 Billion USD | -0.94% |
| 2003 FY | 4.52 Billion USD | 1.64% |
| 2003 Q2 | 4.05 Billion USD | -5.37% |
| 2003 Q3 | 4.4 Billion USD | 8.6% |
| 2003 Q4 | 4.52 Billion USD | 2.62% |
| 2003 Q1 | 4.28 Billion USD | -3.63% |
| 2002 Q4 | 4.44 Billion USD | 11.13% |
| 2002 Q3 | 4 Billion USD | -2.43% |
| 2002 Q2 | 4.1 Billion USD | -8.34% |
| 2002 Q1 | 4.47 Billion USD | 10.21% |
| 2002 FY | 4.44 Billion USD | 9.53% |
| 2001 Q3 | 4.23 Billion USD | 10.09% |
| 2001 Q2 | 3.84 Billion USD | 0.21% |
| 2001 Q1 | 3.83 Billion USD | 5.26% |
| 2001 FY | 4.06 Billion USD | 11.42% |
| 2001 Q4 | 4.06 Billion USD | -4.04% |
| 2000 FY | 3.64 Billion USD | 1.37% |
| 2000 Q2 | 3.74 Billion USD | -4.98% |
| 2000 Q3 | 4.04 Billion USD | 7.95% |
| 2000 Q4 | 3.64 Billion USD | -9.82% |
| 2000 Q1 | 3.94 Billion USD | 9.58% |
| 1999 Q1 | 3.57 Billion USD | -1.32% |
| 1999 Q3 | 3.66 Billion USD | 5.06% |
| 1999 Q4 | 3.59 Billion USD | -1.76% |
| 1999 Q2 | 3.48 Billion USD | -2.62% |
| 1999 FY | 3.59 Billion USD | -0.82% |
| 1998 Q1 | 3.31 Billion USD | 1.19% |
| 1998 Q3 | 3.53 Billion USD | 10.35% |
| 1998 Q4 | 3.62 Billion USD | 2.48% |
| 1998 FY | 3.62 Billion USD | 10.69% |
| 1998 Q2 | 3.2 Billion USD | -3.28% |
| 1997 Q1 | 1.44 Billion USD | -8.86% |
| 1997 Q2 | 3.16 Billion USD | 118.81% |
| 1997 FY | 3.27 Billion USD | 106.43% |
| 1997 Q4 | 3.27 Billion USD | 4.94% |
| 1997 Q3 | 3.12 Billion USD | -1.36% |
| 1996 Q3 | 1.88 Billion USD | 1.96% |
| 1996 FY | 1.58 Billion USD | -31.57% |
| 1996 Q1 | 2.38 Billion USD | 2.79% |
| 1996 Q2 | 1.85 Billion USD | -22.34% |
| 1996 Q4 | 1.58 Billion USD | -15.92% |
| 1995 FY | 2.31 Billion USD | 3.33% |
| 1995 Q4 | 2.31 Billion USD | -20.69% |
| 1995 Q3 | 2.92 Billion USD | 17.58% |
| 1995 Q2 | 2.48 Billion USD | -0.84% |
| 1995 Q1 | 2.5 Billion USD | 11.75% |
| 1994 Q4 | 2.24 Billion USD | -14.23% |
| 1994 Q3 | 2.61 Billion USD | 19.61% |
| 1994 Q2 | 2.18 Billion USD | 1.15% |
| 1994 Q1 | 2.16 Billion USD | 12.03% |
| 1994 FY | 2.24 Billion USD | 16.25% |
| 1993 FY | 1.93 Billion USD | -5.19% |
| 1993 Q1 | 2.16 Billion USD | 6.11% |
| 1993 Q2 | 2.06 Billion USD | -4.33% |
| 1993 Q3 | 2.4 Billion USD | 16.48% |
| 1993 Q4 | 1.93 Billion USD | -19.82% |
| 1992 Q2 | 2.18 Billion USD | -2.22% |
| 1992 FY | 2.03 Billion USD | 7.82% |
| 1992 Q4 | 2.03 Billion USD | -16.61% |
| 1992 Q1 | 2.23 Billion USD | 18.2% |
| 1992 Q3 | 2.44 Billion USD | 11.88% |
| 1991 FY | 1.88 Billion USD | 10.85% |
| 1991 Q1 | 2.08 Billion USD | 22.28% |
| 1991 Q4 | 1.88 Billion USD | -17.13% |
| 1991 Q3 | 2.27 Billion USD | 10.51% |
| 1991 Q2 | 2.06 Billion USD | -1.02% |
| 1990 FY | 1.7 Billion USD | 29.98% |
| 1990 Q1 | 1.5 Billion USD | 15.0% |
| 1990 Q3 | 2.32 Billion USD | 60.0% |
| 1990 Q4 | 1.7 Billion USD | -26.63% |
| 1990 Q2 | 1.45 Billion USD | -3.73% |
| 1989 FY | 1.31 Billion USD | 27.25% |
| 1989 Q1 | 980.6 Million USD | -4.79% |
| 1989 Q2 | 1.18 Billion USD | 21.12% |
| 1989 Q3 | 1.56 Billion USD | 31.66% |
| 1989 Q4 | 1.31 Billion USD | -16.19% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -144582.203% |
| Accuray Incorporated | 423.54 Million USD | -40767.633% |
| Align Technology, Inc. | 2.45 Billion USD | -6955.223% |
| Elevance Health Inc. | 69.52 Billion USD | -148.971% |
| AxoGen, Inc. | 101.16 Million USD | -171003.774% |
| Boston Scientific Corporation | 15.6 Billion USD | -1009.138% |
| Cardinal Health, Inc. | 48.33 Billion USD | -258.124% |
| Centene Corporation | 58.68 Billion USD | -194.951% |
| DaVita Inc. | 14.87 Billion USD | -1063.556% |
| HCA Healthcare, Inc. | 55.15 Billion USD | -213.851% |
| Hologic, Inc. | 4.02 Billion USD | -4199.354% |
| Humana Inc. | 30.74 Billion USD | -462.956% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -9649.492% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -1859.251% |
| Masimo Corporation | 1.67 Billion USD | -10223.373% |
| McKesson Corporation | 69.04 Billion USD | -150.705% |
| Patterson Companies, Inc. | 1.89 Billion USD | -9034.142% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -2176.328% |
| ResMed Inc. | 2 Billion USD | -8518.613% |
| Henry Schein, Inc. | 5.42 Billion USD | -3093.579% |
| Teladoc Health, Inc. | 2.06 Billion USD | -8276.922% |
| Universal Health Services, Inc. | 8.15 Billion USD | -2022.541% |
| Veeva Systems Inc. | 1.26 Billion USD | -13571.317% |
| Baxter International Inc. | 19.8 Billion USD | -773.849% |
| Becton, Dickinson and Company | 26.98 Billion USD | -541.462% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -8367.469% |
| Danaher Corporation | 30.99 Billion USD | -458.397% |
| Stryker Corporation | 21.31 Billion USD | -711.914% |
| Medtronic plc | 39.56 Billion USD | -337.532% |